Navigation Links
Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
Date:12/1/2009

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management's presentation at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1 at 11:00 a.m. Eastern Time will be webcast live at www.celltherapeutics.com.

The presentation will take place in Holmes 1 at the New York Palace Hotel, and will also be available for replay after the presentation.


                     Piper Jaffray Health Care Conference
                  New York Palace Hotel, Holmes 1 (4th Floor)
                  CTI Presentation: Tuesday, December 1, 2009
       11:00 a.m. Eastern /5:00 p.m. Central European /8:00 a.m. Pacific
                   Audio webcast at www.celltherapeutics.com


Media Contact:
Dan Eramian
T: 206.272.4343
C: 206.854.1200
F: 206.272.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/press_room

Investors Contact:
Ed Bell
T: 206.272.4345
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Monogram Energy, Inc. Acquires Triad Therapeutics, Inc.
2. Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5
3. Oxygen Biotherapeutics, Inc. Shareholders Approve Reverse Stock Split
4. Cell Therapeutics, Inc. Annual Meeting of Shareholders Scheduled for Tuesday, October 20, 2009
5. Oxygen Biotherapeutics, Inc. to Present at Investor Conferences in Zurich
6. Oxygen Biotherapeutics, Inc. Posts Blog by CEO Chris Stern on Proposed Reverse Split
7. Cell Therapeutics, Inc.s (CTI) Presentation at BioCentury NewsMakers Conference to be Webcast
8. Oxygen Biotherapeutics, Inc. Posts Latest Blog by CEO Chris Stern
9. Cell Therapeutics, Inc.s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
10. Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland
11. Rx for Africa, Inc. and Zirus, Inc. Create Joint Venture, ZiRx Therapeutics, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us that ... Prevention (CDC), a stroke is the fourth leading cause of death in the United States; ... with almost a quarter of them in individuals under 65 years old. A stroke ...
(Date:4/28/2016)... ... 2016 , ... Point Source Audio® (PSA) , an ... today that the US Patent Office has approved its patent submission that covers ... design creates a lightweight and modular audio headset that has been said to ...
(Date:4/28/2016)... Cary, NC (PRWEB) , ... April 28, 2016 ... ... to announce it has partnered with Community Oncology Pharmacy Association (COPA) to develop ... elevate the practice of oncology by introducing an accreditation distinction. ACHC provides a ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... Pharmacy Discount Cards in the mail from USA Medical Prescription Assistance Program. They ... , Each mailed package will include a ready-to-use, state-themed card and, ...
(Date:4/28/2016)... ... April 28, 2016 , ... For the 10,000 Americans who turn ... an important part of overall well-being: mental health. Now, a new book—Staying Sharp For ... aging and “cognitive vitality,” which can include everything from honing your memory and managing ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016  The ... reached 275 million dollars, according to Kalorama Information and ... includes typing, immunoassays and nucleic acid testing.  The healthcare ... had made progress in developing blood collection stations and ... was made in Kalorama Information,s report, Blood ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: